BB

Bernhard Boidol

CEO

Proxygen

Vienna, Vienna


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Proxygen
Industry
research
Employees
38.0
Seniority
C suite

Technologies

Outlook Greenhouse.io Typekit Apache WordPress.org Mobile Friendly

Keywords

biotechnology research molecular glue degraders protein degradation drug discovery undruggable proteins catalytic degradation targeted protein elimination antibody-drug conjugates ligase recruitment cellular quality control therapeutic innovations biochemical technologies protein recycling mechanisms selective degradation small molecule drugs biotech collaboration pharmaceutical innovation clinical development genomic technologies proteomic analysis biotech partnerships novel drug modalities biological assays e3 ligases target specificity drug candidates therapeutic pipelines cancer therapies translational research proteins as drug targets high medical need discovery platform bioactive small molecules therapeutic applications research collaborations high-throughput screening biomolecular interactions novel cancer treatments scientific advisory board biomedical research strategic partnerships multi-modal therapies research funding target identification treatment modalities biotech start-ups life sciences innovation

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans